1. Pipersarmenoids, new amide alkaloids from Piper sarmentosum.
- Author
-
Zhou K, Han L, Li W, Liu S, Chen T, Chen J, Lv J, Zhou X, Li Q, Meng X, Li H, and Qin L
- Subjects
- Molecular Structure, Animals, Mice, Cell Line, Amides pharmacology, Amides isolation & purification, Amides chemistry, Nitric Oxide metabolism, China, Microglia drug effects, Fatty Acids, Unsaturated, Polyunsaturated Alkamides, Alkaloids pharmacology, Alkaloids isolation & purification, Alkaloids chemistry, Piper chemistry, Cholinesterase Inhibitors pharmacology, Cholinesterase Inhibitors isolation & purification, Plant Components, Aerial chemistry, Phytochemicals pharmacology, Phytochemicals isolation & purification
- Abstract
A chemical investigation of the aerial parts of Piper sarmentosum resulted in the isolation and identification of 14 amide alkaloids, including three new amide alkaloids, pipersarmenoids A - C (1-3), three new natural amide alkaloids, pipersarmenoids D - F (4-6), and 8 known analogues, N-p-coumaroyltyramine (7), piperlotine C (8), piperlotine D (9), pellitorine (10), sarmentine (11), aurantiamide acetate (12), 1-cinnamoyl pyrrolidine (13) and sarmentamide B (14). Their structures were determined by spectroscopic analysis including HRESIMS and 1D and 2D NMR. The cytotoxicity, neuroinflammation-inhibiting and acetylcholinesterase (AChE) inhibitory activities of those compounds were tested. Compounds 1, 2 and 12 inhibited NO production induced by LPS in BV2 cells with IC
50 values of 9.36, 12.53 and 10.77 μM, respectively. Moreover, 1, 2, 7 and 11 showed moderate inhibitory activity on AChE with IC50 values ranging from 37.56 to 48.84 μM., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF